Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Rating of “Moderate Buy” by Brokerages
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price […]
More Stories
NIPPON STL & SU/S (OTCMKTS:NSSMY) Sets New 12-Month Low – Time to Sell?
NIPPON STL & SU/S (OTCMKTS:NSSMY – Get Free Report) hit a new 52-week low on Tuesday . The company traded...
Baidu (NASDAQ:BIDU) Upgraded by StockNews.com to “Buy” Rating
Baidu (NASDAQ:BIDU – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy”...
Beyond Air (NASDAQ:XAIR) Approves Equity Incentive Plan and Stock Option Repricing
On November 22, 2024, Beyond Air, Inc. (NASDAQ:XAIR) announced the approval of its Seventh Amended and Restated 2013 Equity Incentive...
Korea Electric Power (NYSE:KEP) Upgraded to “Buy” at StockNews.com
Korea Electric Power (NYSE:KEP – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to...
Libor Michalek Sells 96,332 Shares of Affirm Holdings, Inc. (NASDAQ:AFRM) Stock
Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) President Libor Michalek sold 96,332 shares of the business’s stock in a...
Insider Selling: MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) Director Sells 12,438 Shares of Stock
MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI – Get Free Report) Director Susan Ocampo sold 12,438 shares of the company’s stock...